PT95093A - Metodos para a culturizacao de hvc em celulas eucarioticas - Google Patents

Metodos para a culturizacao de hvc em celulas eucarioticas

Info

Publication number
PT95093A
PT95093A PT95093A PT9509390A PT95093A PT 95093 A PT95093 A PT 95093A PT 95093 A PT95093 A PT 95093A PT 9509390 A PT9509390 A PT 9509390A PT 95093 A PT95093 A PT 95093A
Authority
PT
Portugal
Prior art keywords
culturization
hvc
methods
cells
eucariotic
Prior art date
Application number
PT95093A
Other languages
English (en)
Other versions
PT95093B (pt
Inventor
Amy J Weiner
Kathelyn S Steimer
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23576300&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT95093(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of PT95093A publication Critical patent/PT95093A/pt
Publication of PT95093B publication Critical patent/PT95093B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24221—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Details Of Audible-Bandwidth Transducers (AREA)
  • Telephone Function (AREA)
  • Measurement Of Mechanical Vibrations Or Ultrasonic Waves (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
PT95093A 1989-08-25 1990-08-24 Metodos para a culturizacao de hvc em celulas eucarioticas PT95093B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39866789A 1989-08-25 1989-08-25

Publications (2)

Publication Number Publication Date
PT95093A true PT95093A (pt) 1991-05-22
PT95093B PT95093B (pt) 1997-11-28

Family

ID=23576300

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95093A PT95093B (pt) 1989-08-25 1990-08-24 Metodos para a culturizacao de hvc em celulas eucarioticas

Country Status (12)

Country Link
EP (1) EP0414475B1 (pt)
JP (3) JPH05502156A (pt)
AT (1) ATE161041T1 (pt)
AU (1) AU655156B2 (pt)
CA (1) CA2064705C (pt)
DE (1) DE69031791T2 (pt)
DK (1) DK0414475T3 (pt)
ES (1) ES2110411T3 (pt)
GR (1) GR3026114T3 (pt)
IE (1) IE903097A1 (pt)
PT (1) PT95093B (pt)
WO (1) WO1991002820A1 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7166287B1 (en) 1989-12-18 2007-01-23 Glaxo Wellcome Inc. Viral agent
CA2032381C (en) 1989-12-18 2006-02-21 Peter E. Highfield Viral agent
AU7672991A (en) * 1990-04-03 1991-10-30 Southwest Foundation For Biomedical Research Purified hcv and hcv proteins and peptides
WO1991015596A1 (en) * 1990-04-04 1991-10-17 Protos, Inc. Hepatitis c virus protease inhibitors
ES2152922T3 (es) * 1990-04-06 2001-02-16 Genelabs Tech Inc Epitopos del virus de la hepatitis c.
US5747339A (en) 1990-06-25 1998-05-05 Research Foundation For Microbial Diseases Of Osaka Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
US5574132A (en) * 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
CA2065690A1 (en) * 1991-04-10 1992-10-11 Hiroaki Okamoto Non-a, non-b hepatitis related antigens, detection systems, polynucleotides and polypeptides
US5428145A (en) * 1991-08-09 1995-06-27 Immuno Japan, Inc. Non-A, non-B, hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody and detection systems
ES2065863T3 (es) 1991-11-21 2003-09-01 Common Services Agency Analisis para la deteccion de virus de la hepatitis c.
US5552310A (en) * 1992-06-12 1996-09-03 Hiroshi Yoshikura Replication of hepatitis C virus genome and identification of virus having high infectivity
AU6943994A (en) * 1993-05-04 1994-11-21 United States Of America, As Represented By The Secretary, Department Of Health And Human Services Hepatitis c virus cell propagation and related methods
US5840565A (en) 1995-08-22 1998-11-24 The Regents Of The University Of California Methods for enhancing the production of viral vaccines in PKR-deficient cell culture
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US5851758A (en) * 1995-10-25 1998-12-22 Childrens Research Institute Cytopathic replication of hepatitis C virus in a new cell line
US6242187B1 (en) 1996-01-29 2001-06-05 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
PL328068A1 (en) * 1996-01-29 1999-01-04 Virologic Compositions for and methods of determining susceptibility to and immunity against an antiviral drug and selecting appropriate antiviral drug
CA2269097C (en) 1996-11-08 2007-01-09 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Synthesis and purification of hepatitis c virus-like particles
US7338759B1 (en) 1997-03-04 2008-03-04 Washington University HCV variants
US7049428B1 (en) 1998-03-04 2006-05-23 Washington University HCV variants
AT407256B (de) * 1998-06-24 2001-02-26 Immuno Ag Hepatitis c-virus positive endometriale zelllinie
US6680059B2 (en) 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
AU2001292151B2 (en) 2000-08-17 2006-05-04 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US6858590B2 (en) 2000-08-17 2005-02-22 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
WO2007031867A2 (en) 2005-05-25 2007-03-22 Tripep Ab A hepatitis c virus non-stru tural ns3/4a fusion gene
WO2009022236A2 (en) 2007-08-16 2009-02-19 Tripep Ab Immunogen platform
WO2009130588A2 (en) 2008-04-22 2009-10-29 Tripep Ab Immunogen platform
GB201119011D0 (en) * 2011-11-03 2011-12-14 Queen Mary Innovation Ltd Method
CN117716024A (zh) * 2021-06-01 2024-03-15 瓦克斯细胞生物 包含饲养细胞的自然杀伤细胞增殖用组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464474A (en) * 1980-07-09 1984-08-07 Connaught Laboratories Limited Non-A, non-B hepatitis assay and vaccine
WO1982002774A1 (en) * 1981-02-11 1982-08-19 Baxter Travenol Lab Non-a,non-b hepatitis virus
WO1987005930A1 (en) * 1986-04-01 1987-10-08 Genelabs Incorporated Immortalized virus-specific tissue cells
BR8807310A (pt) * 1987-11-18 1990-03-13 Chiron Corp Polinucleotidio,polinucleotidio recombinante,vetor recombinante,celula hospedeira,sistema de expressao recombinante,celula transformada,polipeptidio,hcv,preparacao de polipeptidio,polipeptidio de hcv,polipeptidio purificado,polipeptidio recombinante,polipeptidio de fusao,anticorpo monoclonal,preparacao purificada de anticorpos policlonais,particula,sonda de polinucleotidio,kit anticorpo para epetopo de hcv,metodo para producao de polipeptidio,metodo para deteccao de acidos nucleicos de hcv,imunoensaio para detectar antigeno de hcv,imunoensaio para detectar anticorpos dirigidos contra antigeno de hcv,vacina para tratamento de infeccao de hcv,celula,celula infectada com hcv,metodo para producao de anticorpos para hcv e metodo para isolar cdna derivado do genoma de um agente infeccioso nao identificado

Also Published As

Publication number Publication date
DE69031791D1 (de) 1998-01-22
CA2064705C (en) 1999-04-06
PT95093B (pt) 1997-11-28
ATE161041T1 (de) 1997-12-15
WO1991002820A1 (en) 1991-03-07
JPH05502156A (ja) 1993-04-22
EP0414475A1 (en) 1991-02-27
CA2064705A1 (en) 1991-02-26
DK0414475T3 (da) 1998-02-09
ES2110411T3 (es) 1998-02-16
GR3026114T3 (en) 1998-05-29
JP2001314192A (ja) 2001-11-13
AU6344990A (en) 1991-04-03
DE69031791T2 (de) 1998-04-02
EP0414475B1 (en) 1997-12-10
IE903097A1 (en) 1991-02-27
AU655156B2 (en) 1994-12-08
JP2004049235A (ja) 2004-02-19

Similar Documents

Publication Publication Date Title
DK0414475T3 (da) Fremgangsmåder til dyrkning af HCV i B- eller T-lymfocyt-cellelinier
DE3784484D1 (de) Hepatitis nanb-viraler stoff, antigen und immunologisches reagenz.
DK219087A (da) Vektorsystem til brug ved transformation af trichoderma, transformerede trichodermastammer og fremgangsmaade til fremstilling af proteiner heri
PT86640A (pt) Hepatitis b virus surface antigens and hybrid antigens containing them
IL73428A (en) Anti-idiotype antibodies against a tumor or virus,method and cell lines for producing them and compositions containing them
FI870104A7 (fi) Negatiivisia, valosähköisen vastuksen omaavia koostumuksia ja menetelmiä lämmönkestävien negatiivikuvien valmistamiseksi käyttämällä niitä.
FI916135A7 (fi) Kasvatusalusta ja menetelmä sienien, kuten shiitakesienen (Lentinus ed odes) viljelemiseksi
DE58909029D1 (de) Bauelement zur Absorption von Energie.
ATE161040T1 (de) Kultivierung von vero-zellen
BR8400588A (pt) Forno de fusao por inducao em alta frequencia e processo de preparacao de materiais ceramicos,por fusao,por inducao em alta frequencia
BR8107925A (pt) Processo e gabarito para construcao de moveis
DE69534595D1 (de) Methode zur proliferation und differenzierung von b-zellen und verwendungen dafür
MY101236A (en) Grid ceiling
DE3476221D1 (en) Method for obtaining human hepatocytes cultures, cultures obtained thereby and biological and biochemical applications thereof
ATE114713T1 (de) Biomasse zur produktion von virus/virusantigen.
IE801818L (en) Hepatitis a culture in vitro
DE69021496D1 (de) Integrierter Prozess zur Produktion von Diisopropylether und Benzin.
EP0019218A3 (en) Influenza virus vaccines, process for preparing them, process for propagating influenza viruses and cell culture inoculated with influenza virus
ES2177531T3 (es) Receptor de lipoproteinas de baja densidad (ldl), su produccion y su utilizacion.
DK713188A (da) Fremgangsmaade til fremstilling af pregneno-oxazoliner
DK628188A (da) Protein og fremgangsmaade til fremstilling deraf
BG35041A3 (bg) Метод за получаване на заместени 2-пиперидин-4-амино-6,7- диметоксихиназолини
DE59410140D1 (de) Rinderovarzellinie (FROv) zur Virusvermehrung
JPS55126247A (en) Fixing method for photomask substrate
SE9303219D0 (sv) Containerok

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19901214

FG3A Patent granted, date of granting

Effective date: 19970826

PD4A Change of proprietorship

Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC., US

Effective date: 20080215

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20120827